Long-term safety and efficacy of CART-20 cells in patients with refractory or relapsed B-cell non-Hodgkin lymphoma: 5-years follow-up results of the phase I and IIa trials
Wen-ying Zhang,Yang Liu,Yao Wang,Chun-meng Wang,Qing-ming Yang,Hong-li Zhu &…Wei-dong Han
